Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 via induction of trained immunity and SARS-CoV-2 reactive mucosal T cells
RNA-seq (gene expression) · mouse · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 15 samples: 4 × Mock vs 4 × RSV vs 4 × RSV/SARS-CoV2 vs 3 × Mock/ SARS-CoV2Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cellsJournal of virology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE300910_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1282658 and SRA study SRP594893. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 4 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9071860 Mock_1 Mock
- GSM9071861 Mock_2 Mock
- GSM9071862 Mock_3 Mock
- GSM9071863 Mock_4 Mock
- GSM9071864 RSV1 RSV
- GSM9071865 RSV2 RSV
- GSM9071866 RSV3 RSV
- GSM9071867 RSV4 RSV
- GSM9071868 Mock/ SARS-CoV2_1 Mock/ SARS-CoV2
- GSM9071869 Mock/ SARS-CoV2_2 Mock/ SARS-CoV2
- GSM9071870 Mock/ SARS-CoV2_3 Mock/ SARS-CoV2
- GSM9071871 RSV/SARS-CoV2_1 RSV/SARS-CoV2
- GSM9071872 RSV/SARS-CoV2_2 RSV/SARS-CoV2
- GSM9071873 RSV/SARS-CoV2_3 RSV/SARS-CoV2
- GSM9071874 RSV/SARS-CoV2_4 RSV/SARS-CoV2
- GSE329370 Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection 26 samples shares sars-cov-2, immunity
- GSE270802 Diabetes induces exacerbated SARS-CoV-2 replication partly associated with ineffective pulmonary interferon responses, delayed cell-mediated immunity, and disruption of leptin receptor signaling 24 samples shares sars-cov-2, immunity
- GSE253635 Interferon-lambda uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I interferon 18 samples shares sars-cov-2, immunity
- GSE329366 Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection [FLOX] 10 samples shares sars-cov-2, immunity
- GSE329365 Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection [Lung4Day] 8 samples shares sars-cov-2, immunity
- GSE284691 Lung tissue-resident memory T cells optimize protection by IL-10 regulation of innate immunity 43 samples shares protection, immunity
- GSE292434 Heterologous Prime-Boost Immunization of AAV-based Neoantigen Cancer Vaccine Induces Anti-Tumor Immunity to Inhibit Tumor Growth and Relapse 12 samples shares heterologous, immunity
- GSE243289 Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade 30 samples shares protection, induction
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.